LEEM wants more women in French drug industry

20 April 2008

France's drug industry representative body (LEEM) has signed an accord with the Force Femmes association to introduce a procedure designed to encourage more women to apply for positions in the pharmaceutical sector. One of the new measures under consideration is the extension of the existing anonymized resume system, established with the SOS Racisme antiracism group, to ensure that applicants' ethnic origin is not identifiable at the initial application stage (Marketletter December 10, 2007).

The scheme is geared towards helping women who are returning to the workforce, although the drug industry in France's 103,500 employees are already mostly women (58%), according to 2006 figures.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight